Brain zaps after antidepressant discontinuation: Heterogeneous responses across paroxetine, venlafaxine, and duloxetine—a three-case letter

Akdogan, Turceun Ileri

doi:10.14744/DAJPNS.2026.00331

Letter to The Editor

Brain zaps after antidepressant discontinuation: Heterogeneous responses across paroxetine, venlafaxine, and duloxetine—a three-case letter

Turceun Ileri Akdogan ¹

¹Rize State Hospital, Department of Psychiatry, Rize, Turkiye

Dusunen Adam J Psychiatr Neurol Sci 2026; 39(2): 162-164 DOI: 10.14744/DAJPNS.2026.00331

Full Text PDF

Akdogan TI. Brain zaps after antidepressant discontinuation: Heterogeneous responses across paroxetine, venlafaxine, and duloxetine—a three-case letter. Dusunen Adam J Psychiatr Neurol Sci. 2026 ;39(2):162-164. doi: 10.14744/DAJPNS.2026.00331.

Akdogan TI. Brain zaps after antidepressant discontinuation: Heterogeneous responses across paroxetine, venlafaxine, and duloxetine—a three-case letter. Dusunen Adam J Psychiatr Neurol Sci. 2026;39(2):162-164. doi: 10.14744/DAJPNS.2026.00331

Akdogan, T. I. (2026). Brain zaps after antidepressant discontinuation: Heterogeneous responses across paroxetine, venlafaxine, and duloxetine—a three-case letter. Dusunen Adam Journal of Psychiatry and Neurological Sciences, 39(2), 162-164. https://doi.org/10.14744/DAJPNS.2026.00331

Akdogan, T. I.. "Brain zaps after antidepressant discontinuation: Heterogeneous responses across paroxetine, venlafaxine, and duloxetine—a three-case letter." Dusunen Adam Journal of Psychiatry and Neurological Sciences, vol. 39, no. 2, 2026, pp. 162-164. https://doi.org/10.14744/DAJPNS.2026.00331.

Akdogan, T. I.. 2026. "Brain zaps after antidepressant discontinuation: Heterogeneous responses across paroxetine, venlafaxine, and duloxetine—a three-case letter." Dusunen Adam Journal of Psychiatry and Neurological Sciences 39, no. 2: 162-164. https://doi.org/10.14744/DAJPNS.2026.00331.

Journal Display Format:

Authors: Turceun Ileri Akdogan
Article Title: Brain zaps after antidepressant discontinuation: Heterogeneous responses across paroxetine, venlafaxine, and duloxetine—a three-case letter
Journal Name: Dusunen Adam Journal of Psychiatry and Neurological Sciences
Year: 2026
Volume: 39
Issue: 2
Pages: 162 - 164
DOI: 10.14744/DAJPNS.2026.00331

RIS BibTeX EndNote Medlars